1. Overcoming technological and biological barriers to pulmonary mRNA delivery with lipid-polymer hybrid nanoparticles
Biesel A, Shandheep A, Pavlou A, Busker Lm, Koch M, Kopliku V, Et Al.
Delivering mRNA to the lungs promises treatment of genetic, infectious and non-communicable lung diseases. Yet, conventional lipid nanoparticle formulations lack the stability needed to endure the harsh mechanical stress during nebulization. Additionally, once deposited in the respiratory tract, gene delivery systems…
- DLin-MC3-DMA
- DOTAP
- Lung epithelial cells
- Microfluidics
- Poly(lactic-co-glycolic) acid
- Vibrating mesh nebulization
